HRTX - Heron Therapeutics, Inc. - Optionskæde

Heron Therapeutics, Inc.
US ˙ NasdaqCM ˙ US4277461020

Udløb
Puts for markedsdato June 03, 2026
Kontrakt Strejke Bud Spørg Sidst Bind HEJ IV Delta Gamma Theta Vega Rho
HRTX20260618P00000500 0.50 0.00 0.10 0.05 111 200 120.29% -0.65 4.04 -0.00 0.00 -0.00
HRTX20260618P00001000 1.00 0.10 0.60 0.00 0 313 422.34% -0.71 0.97 -0.00 0.00 -0.00
HRTX20260618P00001500 1.50 0.55 1.55 0.00 0 0 0.00% 0.00 0.00 0.00 0.00 0.00
HRTX20260618P00002000 2.00 1.10 2.10 0.00 0 10 593.39% -0.76 0.64 -0.01 0.00 -0.00
HRTX20260618P00003000 3.00 2.00 3.00 0.00 0 0 0.00% 0.00 0.00 0.00 0.00 0.00
HRTX20260618P00004000 4.00 3.00 4.00 0.00 0 0 0.00% 0.00 0.00 0.00 0.00 0.00
HRTX20260618P00005000 5.00 4.00 5.00 4.51 2 10 0.00% 0.00 0.00 0.00 0.00 0.00
Calls for markedsdato June 03, 2026
Kontrakt Strejke Bud Spørg Sidst Bind HEJ IV Delta Gamma Theta Vega Rho
HRTX20260618C00000500 0.50 0.00 0.05 0.05 40 1,014 114.65% 0.40 3.83 -0.00 0.00 0.00
HRTX20260618C00001000 1.00 0.00 0.05 0.01 9 1,299 328.38% 0.21 0.98 -0.00 0.00 0.00
HRTX20260618C00001500 1.50 0.00 0.05 0.00 0 1,340 424.41% 0.18 0.69 -0.00 0.00 0.00
HRTX20260618C00002000 2.00 0.00 0.05 0.00 0 2,139 486.44% 0.17 0.57 -0.00 0.00 0.00
HRTX20260618C00003000 3.00 0.00 0.50 0.05 1 21 0.00% 0.00 0.00 0.00 0.00 0.00
HRTX20260618C00004000 4.00 0.00 0.95 0.00 0 29 0.00% 0.00 0.00 0.00 0.00 0.00
HRTX20260618C00005000 5.00 0.00 1.00 0.00 0 0 0.00% 0.00 0.00 0.00 0.00 0.00
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
GB:0J4V 0,83 $
DE:AXD2 0,75 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista